HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing Jia Selected Research

Hepatocellular Carcinoma (Hepatoma)

10/2023Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study.
8/2023IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III Study.
1/2018Therapeutic effects of tyroserleutide on lung metastasis of human hepatocellular carcinoma SK-HEP-1 and its mechanism affecting ICAM-1 and MMP-2 and -9.
2/2014Effects of Tyroserleutide on phosphatidylinositol 3'-kinase/AKT pathway in human hepatocellular carcinoma cell.
11/2008Tripeptide tyroserleutide plus doxorubicin: therapeutic synergy and side effect attenuation.
10/2008[Evaluation of the inhibitory effect of tripeptide tyroservatide on growth of human hepatocellular carcinoma using a hollow fiber assay].
2/2008Effects of tyroserleutide on gene expression of calmodulin and PI3K in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jing Jia Research Topics

Disease

69Neoplasms (Cancer)
01/2024 - 09/2005
15Neoplasm Metastasis (Metastasis)
10/2023 - 01/2013
14Inflammation (Inflammations)
04/2024 - 02/2017
10Prostatic Neoplasms (Prostate Cancer)
01/2023 - 02/2016
10Stomach Neoplasms (Stomach Cancer)
11/2021 - 04/2007
7Hepatocellular Carcinoma (Hepatoma)
10/2023 - 02/2008
7Melanoma (Melanoma, Malignant)
01/2023 - 04/2007
6Infections
09/2023 - 05/2015
6Atherosclerosis
01/2023 - 01/2019
6Hypoxia (Hypoxemia)
10/2022 - 03/2015
5Neuroinflammatory Diseases
03/2024 - 11/2017
5Breast Neoplasms (Breast Cancer)
02/2023 - 04/2007
5Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 01/2014
5Lung Neoplasms (Lung Cancer)
09/2017 - 04/2007
5Pulmonary Hypertension
07/2015 - 07/2011
4Liver Neoplasms (Liver Cancer)
08/2023 - 11/2008
4Carcinoma (Carcinomatosis)
02/2023 - 04/2007
4Carcinogenesis
01/2022 - 01/2011
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 06/2013
4Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
10/2015 - 03/2012
3Atrophy
05/2024 - 11/2023
3Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 01/2020
3Stroke (Strokes)
03/2024 - 01/2017
3Hypertension (High Blood Pressure)
10/2022 - 01/2019
3Hot Flashes
01/2022 - 01/2018
3Cognitive Dysfunction
01/2022 - 01/2018
3B-Cell Lymphoma (Lymphoma, B Cell)
10/2021 - 12/2016
3COVID-19
10/2021 - 08/2020
3Heart Failure
09/2020 - 01/2017
3Disease Progression
06/2019 - 01/2013
2Facial Pain (Myofacial Pain)
05/2024 - 06/2022
2Amblyopia (Lazy Eye)
02/2024 - 01/2024
2Pneumonia (Pneumonitis)
01/2024 - 09/2023
2Sepsis (Septicemia)
11/2023 - 01/2022
2Gestational Diabetes (Gestational Diabetes Mellitus)
10/2023 - 12/2020
2Hypersensitivity (Allergy)
09/2023 - 12/2022
2Reperfusion Injury
10/2022 - 08/2022
2Brain Injuries (Brain Injury)
08/2022 - 01/2022
2Brain Ischemia (Cerebral Ischemia)
08/2022 - 04/2021
2Ischemic Stroke
05/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
05/2024 - 03/2006
7Biomarkers (Surrogate Marker)IBA
07/2023 - 02/2008
7Messenger RNA (mRNA)IBA
10/2021 - 03/2006
7MicroRNAs (MicroRNA)IBA
01/2021 - 01/2011
6Glucose (Dextrose)FDA LinkGeneric
01/2024 - 06/2017
6Small Interfering RNA (siRNA)IBA
10/2023 - 07/2015
5Estrogens (Estrogen)FDA Link
05/2024 - 01/2018
5Peptides (Polypeptides)IBA
10/2023 - 06/2008
5Long Noncoding RNAIBA
01/2023 - 06/2016
5CytokinesIBA
01/2022 - 07/2011
5H-Tyr-Ser-Leu-OHIBA
01/2018 - 06/2006
5tripeptide tyroservatideIBA
01/2016 - 03/2006
4CalciumIBA
11/2023 - 03/2015
4RNA (Ribonucleic Acid)IBA
01/2022 - 10/2016
4Imatinib Mesylate (Gleevec)FDA Link
10/2015 - 03/2012
3AntioxidantsIBA
05/2024 - 04/2021
3EnzymesIBA
01/2024 - 01/2019
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2024 - 11/2008
3LipopolysaccharidesIBA
11/2023 - 01/2022
3CateninsIBA
10/2023 - 03/2017
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2023 - 03/2015
3Docetaxel (Taxotere)FDA Link
01/2023 - 10/2017
3Interleukin-6 (Interleukin 6)IBA
12/2022 - 08/2020
3InterleukinsIBA
12/2022 - 02/2017
3CholesterolIBA
10/2022 - 10/2020
3Polysaccharides (Glycans)IBA
07/2021 - 05/2011
3Transforming Growth Factors (Transforming Growth Factor)IBA
12/2018 - 05/2016
3Caspase 3 (Caspase-3)IBA
10/2017 - 10/2016
3Factor V (Coagulation Factor V)IBA
08/2017 - 02/2016
3cholesteryl-6-pyrenylhexanoate (ChPH)IBA
07/2015 - 03/2015
3TRPC6 Cation ChannelIBA
07/2015 - 02/2014
2SaponinsIBA
04/2024 - 04/2021
2Immunologic Factors (Immunomodulators)IBA
04/2024 - 07/2021
2ThioredoxinsIBA
03/2024 - 01/2022
2DNA (Deoxyribonucleic Acid)IBA
01/2024 - 06/2019
2ChromatinIBA
01/2024 - 06/2016
2Histones (Histone)IBA
01/2024 - 03/2006
2Oxygen (Dioxygen)IBA
01/2024 - 04/2021
2Lactic Acid (Lactate)FDA LinkGeneric
01/2024 - 01/2021
2Indicators and Reagents (Reagents)IBA
10/2023 - 01/2014
2Sorafenib (BAY 43-9006)FDA Link
10/2023 - 08/2023
2BilirubinIBA
10/2023 - 12/2016
2Bevacizumab (Avastin)FDA Link
10/2023 - 08/2023
2atezolizumabIBA
10/2023 - 08/2023
2Local AnestheticsIBA
09/2023 - 01/2022
2artenimol (dihydroartemisinin)IBA
01/2023 - 09/2022
2Untranslated RNA (Noncoding RNA)IBA
01/2023 - 01/2018
2DexmedetomidineFDA Link
12/2022 - 07/2021
2AMP-Activated Protein KinasesIBA
10/2022 - 01/2021

Therapy/Procedure

17Therapeutics
10/2023 - 06/2008
7Drug Therapy (Chemotherapy)
02/2023 - 11/2008
3Aftercare (After-Treatment)
01/2024 - 10/2008
3Radiotherapy
07/2023 - 01/2015
3Castration
01/2023 - 01/2019
3Chinese Traditional Medicine (Traditional Chinese Medicine)
09/2020 - 01/2017
2Ovariectomy (Oophorectomy)
05/2024 - 01/2013
2Artificial Respiration (Mechanical Ventilation)
05/2024 - 11/2023
2Mechanical Ventilators (Ventilator)
05/2024 - 11/2023
2Immunotherapy
10/2023 - 05/2011
2Length of Stay
12/2022 - 01/2018